Open AccessAn Updated Review of Target‐Specific Oral Anticoagulants Used in Stroke Prevention in Atrial Fibrillation, Venous Thromboembolic Disease, and Acute Coronary Syndromes
Author(s) -
Cove Christina L.,
Hylek Elaine M.
Publication year - 2013
Publication title -
journal of the american heart association
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.494
H-Index - 85
ISSN - 2047-9980
DOI - 10.1161/jaha.113.000136
Subject(s) - medicine , atrial fibrillation , stroke (engine) , population , cardiology , acute coronary syndrome , warfarin , intensive care medicine , myocardial infarction , mechanical engineering , engineering , environmental health
Atrial fibrillation (AF) is a common arrhythmia in the adult population. It is associated with up to a 5-fold increased risk of stroke and contributes to a higher morbidity and mortality compared with non–AF-related strokes.[1][1] The current prevalence of AF in the adult population, estimated at